← Companies
BioXcel Therapeutics
Top Insights
  • Contribute something unique about BioXcel Therapeutics that may be helpful for others (ex. interview tips, choosing teams, unique culture, etc).

  • About

    BioXcel Therapeutics, Inc. is a clinical-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. BioXcel's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and proprietary machine learning algorithms to identify new therapeutic indices. BioXcel's two most advanced clinical development programs are BXCL501, an investigational, proprietary, orally dissolving thin film formulation of dexmedetomidine for the treatment of agitation and opioid withdrawal symptoms, and BXCL701, an investigational, orally administered, systemic innate immunity activator in development for the treatment of aggressive forms of prostate cancer and advanced solid tumors that are refractory or treatment naΓ―ve to checkpoint inhibitors.

    http://www.bioxceltherapeutics.com
    Website
    2017
    Year Founded
    90
    # of Employees
    $10M-$50M
    Estimated Revenue
    Headquarters

    Get Verified Salaries in your Inbox

    Subscribe to verified offers. You’ll get the breakdown of compensation details by email. Learn More β†’

    This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.